Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine whether daily treatment with tiotropium
(Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of
decline in lung function over time in patients with COPD.